New mixed matrix membrane for the removal of urea from dialysate solution

Ilaria Geremia, Jacobus A.W. Jong, Cornelus F. van Nostrum, Wim E. Hennink, Karin G.F. Gerritsen, Dimitrios Stamatialis*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Urea removal is one of the biggest challenges in dialysate regeneration in Wearable Artificial Kidney (WAK) devices. In this work, a new Mixed Matrix Membrane (MMM) is developed for urea removal in WAK applications. The MMM consists of polystyrene-based ninhydrin particles within a polyethersulfone/polyvinylpyrrolidone polymer blend matrix. The MMM is prepared via dry-wet spinning technique and characterized in terms of its morphology via electron microscopy and clean water permeance. Urea removal is studied both in static and in dynamic conditions. Thanks to the good dispersion of small size ninhydrin particles (size < 63 µm), the MMM removed under static conditions, at 70 °C, 2.1 ± 0.1 mmol of urea per grams of particles at 24 h, while urea removal by the particles in suspension reached 1.7 ± 0.1 mmol/g under the same conditions. Importantly, in continuous recirculation experiments, performed at 70 °C using a laboratory scale module, the MMM removed 3.4 ± 0.3 mmol of urea per grams of particles, in 4 h, due to the high particle accessibility by urea within the membrane. Based on these results it is estimated that only 215 g of MMM are needed for removing the daily produced urea from spent dialysate (400 mmol) making MMM suitable for application to WAK, where miniaturization and lightweight are required.

Original languageEnglish
Article number119408
Pages (from-to)1-6
Number of pages8
JournalSeparation and Purification Technology
Volume277
DOIs
Publication statusPublished - 15 Dec 2021

Bibliographical note

Funding Information:
D. Stamatialis and K. Gerritsen acknowledge the financial support by the Strategic Alliance of the University of Twente , University of Utrecht, and University Medical Center Utrecht and the “European Uremic Toxin working group” (EUTox) of the “European Society for Artificial Organs” (ESAO) endorsed by the “European Renal Association-European Dialysis Transplantation Association” (ERA-EDTA), of which D. Stamatialis is a member.

Funding Information:
I. Geremia acknowledges the financial support of Health-Holland TKI project NOVAMEM (project no: LSHM16059-SGF). D. Stamatialis and K. Gerritsen acknowledge the financial support by the Strategic Alliance of the University of Twente, University of Utrecht, and University Medical Center Utrecht and the ?European Uremic Toxin working group? (EUTox) of the ?European Society for Artificial Organs? (ESAO) endorsed by the ?European Renal Association-European Dialysis Transplantation Association? (ERA-EDTA), of which D. Stamatialis is a member. J. A. W. Jong, C. F. van Nostrum, W. Hennink and K. G. F. Gerritsen acknowledge the financial support of Dutch organization for Scientific Research NWO-TTW (project no: 14433) and of the Dutch Kidney Foundation.

Funding Information:
I. Geremia acknowledges the financial support of Health-Holland TKI project NOVAMEM (project no: LSHM16059-SGF).

Funding Information:
J. A. W. Jong, C. F. van Nostrum, W. Hennink and K. G. F. Gerritsen acknowledge the financial support of Dutch organization for Scientific Research NWO-TTW (project no: 14433) and of the Dutch Kidney Foundation.

Publisher Copyright:
© 2021 The Authors

Funding

D. Stamatialis and K. Gerritsen acknowledge the financial support by the Strategic Alliance of the University of Twente , University of Utrecht, and University Medical Center Utrecht and the “European Uremic Toxin working group” (EUTox) of the “European Society for Artificial Organs” (ESAO) endorsed by the “European Renal Association-European Dialysis Transplantation Association” (ERA-EDTA), of which D. Stamatialis is a member. I. Geremia acknowledges the financial support of Health-Holland TKI project NOVAMEM (project no: LSHM16059-SGF). D. Stamatialis and K. Gerritsen acknowledge the financial support by the Strategic Alliance of the University of Twente, University of Utrecht, and University Medical Center Utrecht and the ?European Uremic Toxin working group? (EUTox) of the ?European Society for Artificial Organs? (ESAO) endorsed by the ?European Renal Association-European Dialysis Transplantation Association? (ERA-EDTA), of which D. Stamatialis is a member. J. A. W. Jong, C. F. van Nostrum, W. Hennink and K. G. F. Gerritsen acknowledge the financial support of Dutch organization for Scientific Research NWO-TTW (project no: 14433) and of the Dutch Kidney Foundation. I. Geremia acknowledges the financial support of Health-Holland TKI project NOVAMEM (project no: LSHM16059-SGF). J. A. W. Jong, C. F. van Nostrum, W. Hennink and K. G. F. Gerritsen acknowledge the financial support of Dutch organization for Scientific Research NWO-TTW (project no: 14433) and of the Dutch Kidney Foundation.

Keywords

  • Dialysate
  • Haemodialysis
  • Mixed Matrix Membrane
  • Ninhydrin
  • Urea

Fingerprint

Dive into the research topics of 'New mixed matrix membrane for the removal of urea from dialysate solution'. Together they form a unique fingerprint.

Cite this